Patients with DDX41 mutations who develop MDS/AML usually present with leukopenia with or without other cytopenias and macrocytosis, in addition to hypocellular bone marrow with prominent erythroid dysplasia, and a normal karyotype, often leading to erythroleukemia (266). The gene discussed is DDX41; the disease is myelodysplastic syndrome.